We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Does Vanguard’s entry into the UK market mark the end of the line for this top FTSE 100 growth stock?

Shares of this investor favourite are down over 5% this week on news. But is it time to flee or time to buy?

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

As an American who invests with Vanguard and can’t say enough good things about the company’s role in lowering fees across the industry, I was thrilled when it announced this week that for the first time it will open its platform directly to UK investors.

Unsurprisingly, the news that the king of cheap investing was entering the market sent the share price of the UK’s largest retailer broker, Hargreaves Lansdown (LSE: HL), down around 5% over the course of the week. But does aggressive new competition mark the end of the long growth story for Hargreaves?

Should you buy Hargreaves Lansdown Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Well, it appears almost certain that a price war will break out sooner rather than later. Vanguard is now offering investors a limited range of ISAs with an annual fee of 0.15% capped at £375 per year, while Hargreave’s own ISAs charge an administration fee of 0.45% per year on assets up to £250,000. Together with the fact that Vanguard’s average fund charges only 0.14% annually, this certainly suggests that most investors looking to passively invest would be better off with Vanguard.

In the short term, HL is somewhat protected as it still offers a broader range of accounts than Vanguard and also offers access to other manager’s funds. That said, Vanguard’s history in the US suggests it will aggressively roll out new funds and account types and progressively lower fees as its AUM snowballs.

For HL and other brokers this will likely end with lower margins as they are forced to cut fees in order to compete with non-profit Vanguard. With operating margins for the six months to December an astounding 70.6%, this won’t be a life or death situation for HL for the time being, but it’s certainly not to be welcomed.

However, with the company’s shares priced very highly at 31 times forward earnings any downward pressure on margins and growth could be hugely detrimental to the company’s lofty valuation. HL remains a highly profitable, diversified business but increasing competition and a very high valuation are enough for me to balk at buying the company’s shares today.

A safer growth dividend option?

A more attractively priced financial stock is corporate stockbroker Numis (LSE: NUM), whose shares trade at just 13 times forward earnings while offering a 4.35% dividend yield that is covered 1.95 times by earnings.

The firm has been growing at a steady clip by focusing on consolidating its position as the go-to broker for small and mid-cap companies seeking to raise funds. Even though IPO markets were quiet last year, this approach paid off as revenue increased 15% year-on-year to £112m and pre-tax profits leapt a full 25% to £32.5m.

This performance was due to the company’s diversified approach to business that encompasses everything from M&A advisory to primary and secondary fund raising, research and trading that continues to win new clients and maintain existing ones.

Also attractive is the fact that the business is highly profitable, with operating margins creeping up to 28.9% last year. And while the company’s fortunes are tied to the optimism of its clients’ willingness to raise funds or undertake M&A, Numis’s healthy balance sheet has £129m in net cash, which provides significant downside protection should market confidence plummet. With impressive market share growth, high margins, a bumper dividend and plenty of cash Numis looks to me an attractively priced share for the long run.

Ian Pierce has no position in any shares mentioned. The Motley Fool UK has recommended Hargreaves Lansdown. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

By mid-2027, analysts expect £5,000 in Barclays shares to be worth…

Barclays shares have outperformed the FTSE 100 by a wide margin over the last year. And City analysts expect to…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Near 5-year lows, here’s what the experts say about the Diageo share price

Ben McPoland's questioning his sanity after investing in Diageo. Where do institutional analysts see its share price heading over the…

Read more »

British Airways cabin crew with mobile device
Investing Articles

Up 165% but still with a P/E of 7.9. Is the IAG share price a generational bargain?

The IAG share price has been on fire for the last two years, delivering some of the biggest returns in…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s the latest Vodafone share price forecasts for 2027

Up 35% in 12 months, the Vodafone share price is beating the stock market right now, but can this momentum…

Read more »